Bausch Health Companies Inc (BHC)

25.93
+0.89(+3.55%)
After Hours
25.76
-0.17(-0.66%)
- Real-time Data
  • Volume:
    3,365,776
  • Bid/Ask:
    25.75/26.00
  • Day's Range:
    24.96 - 26.02

BHC Overview

Prev. Close
25.04
Day's Range
24.96-26.02
Revenue
8.48B
Open
25.29
52 wk Range
14.86-34.8
EPS
-3.6
Volume
3,365,776
Market Cap
9.3B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
2,199,349
P/E Ratio
-
Beta
1.73
1-Year Change
33.25%
Shares Outstanding
358,808,755
Next Earnings Date
Nov. 09, 2021
What is your sentiment on Bausch Health Companies Inc?
or
Market is currently closed. Voting is open during market hours.

Bausch Health Companies Inc News

Bausch Health Companies Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuySellStrong SellSell
Technical IndicatorsStrong BuyStrong BuySellStrong SellStrong Buy
SummaryStrong BuyStrong BuySellStrong SellNeutral

Bausch Health Companies Inc Company Profile

Bausch Health Companies Inc Company Profile

Employees
21600

Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Read More
  • bullish
    0
    • will look at this again at around $25, bearish till then
      0
      • sorry...who wrote the next comment.
        1
        • sing it! dreaming..... only dreaming. at what point do analyst get banned for 'fake' analysis?
          0
          • I do not trust analyst target. Last earnings did not meet analyst expectations. May be long term will reach target 90.00. I bought at 29.00 and sold at 35.00. I follow the chart and will buy again below 30.00.
            4
            • Analyst target for VRX is $90 I am in with 50 shares at $36 hoping analyst to be right this time about $90 target So should I be long on this stock ? Please share your comments
              0
              • Stay AWAY!!!!! Dangerous. Clinton will hit on Pharma constraints tonight. With 36 you will be ok in the long run, 6% as of now and have a feeling that 4% more is on the way
                0
              • Jeremiah Cox . re: "have a feeling", never be emotional about the markets.......it'd hurt you
                0
            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.